HFS
NVAX icon

Hantz Financial Services’s Novavax NVAX Stock Holding History

Hantz Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Buy
449
+400
+816% +$3.63K ﹤0.01% 2222
2025
Q4 		$0 Hold
49
– – ﹤0.01% 2498
2025
Q3 		$0 Sell
49
-15
-23% -$117 ﹤0.01% 2415
2025
Q2 		$0 Hold
64
– – ﹤0.01% 2265
2025
Q1 		$0 Hold
64
– – ﹤0.01% 1895
2024
Q4 		$1K Hold
64
– – ﹤0.01% 1048
2024
Q3 		$1K Hold
64
– – ﹤0.01% 1032
2024
Q2 		$1K Sell
64
-6
-9% -$60 ﹤0.01% 1012
2024
Q1 		$0 Sell
70
-262
-79% -$1.22K ﹤0.01% 1270
2023
Q4 		$2K Hold
332
– – ﹤0.01% 1035
2023
Q3 		$2K Buy
332
+10
+3% +$80 ﹤0.01% 1028
2023
Q2 		$2K Hold
322
– – ﹤0.01% 996
2023
Q1 		$2K Buy
322
+5
+2% +$46 ﹤0.01% 1005
2022
Q4 		$3K Hold
317
– – ﹤0.01% 933
2022
Q3 		$6K Buy
317
+86
+37% +$3.73K ﹤0.01% 823
2022
Q2 		$12K Buy
231
+50
+28% +$2.59K ﹤0.01% 720
2022
Q1 		$13K Buy
181
+95
+110% +$8.47K ﹤0.01% 754
2021
Q4 		$12K Buy
+86
New +$14.8K ﹤0.01% 681

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hantz Financial Services's NVAX Position: Q1 2026 in Review

Hantz Financial Services increased its Novavax (NVAX) stake by 816% in Q1 2026, buying an estimated $3.63K and bringing the position to 449 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2222.

Hantz Financial Services first reported a position in NVAX in Q4 2021 and has held it in 18 quarters since. The position peaked at $13K in Q1 2022. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Hantz Financial Services held 449 shares of Novavax worth $4K as of Q1 2026.
  • Hantz Financial Services bought 400 Novavax shares in Q1 2026, an estimated $3.63K.
  • Novavax made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2222 holding.
  • Hantz Financial Services first reported a position in Novavax in Q4 2021 and has held it in 18 quarters since.
  • Hantz Financial Services's Novavax position peaked at $13K in Q1 2022.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.